On January 27, 2025, Novo Nordisk A/S reported on its ongoing share repurchase program initiated on November 11, 2024, committing up to DKK 20 billion, with DKK 19.6 billion already utilized to repurchase 24,221,173 B shares at an average price of DKK 811.08, representing 0.6% of its share capital.